Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Onyx shares fall on likely delay in myeloma drug approval
Onyx shares fall on likely delay in myeloma drug approval
Onyx shares fall on likely delay in myeloma drug approval
Submitted by
admin
on December 12, 2011 - 11:04am
Source:
Reuters
News Tags:
ONYX Pharmaceuticals
myeloma
Carfilzomib
FDA
Headline:
Onyx shares fall on likely delay in myeloma drug approval
Do Not Allow Advertisers to Use My Personal information
